[go: up one dir, main page]

MX2016007984A - Nuevo compuesto para el tratamiento de hipoglucemia severa. - Google Patents

Nuevo compuesto para el tratamiento de hipoglucemia severa.

Info

Publication number
MX2016007984A
MX2016007984A MX2016007984A MX2016007984A MX2016007984A MX 2016007984 A MX2016007984 A MX 2016007984A MX 2016007984 A MX2016007984 A MX 2016007984A MX 2016007984 A MX2016007984 A MX 2016007984A MX 2016007984 A MX2016007984 A MX 2016007984A
Authority
MX
Mexico
Prior art keywords
treatment
novel compound
severe hypoglycemia
hypoglycemia
severe
Prior art date
Application number
MX2016007984A
Other languages
English (en)
Inventor
Alsina-Fernandez Jorge
Chadwick Cummins Robert
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52278803&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2016007984(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of MX2016007984A publication Critical patent/MX2016007984A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/605—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Removal Of Specific Substances (AREA)

Abstract

La presente invención se refiere a un nuevo compuesto útil en el tratamiento de hipoglucemia.
MX2016007984A 2013-12-18 2014-12-11 Nuevo compuesto para el tratamiento de hipoglucemia severa. MX2016007984A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361917658P 2013-12-18 2013-12-18
PCT/US2014/069646 WO2015094878A1 (en) 2013-12-18 2014-12-11 Novel compound for treatment of severe hypoglycemia

Publications (1)

Publication Number Publication Date
MX2016007984A true MX2016007984A (es) 2016-09-09

Family

ID=52278803

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016007984A MX2016007984A (es) 2013-12-18 2014-12-11 Nuevo compuesto para el tratamiento de hipoglucemia severa.

Country Status (26)

Country Link
US (1) US9688736B2 (es)
EP (1) EP3083669A1 (es)
JP (1) JP2017503782A (es)
KR (1) KR20160077215A (es)
CN (1) CN105793282A (es)
AP (1) AP2016009268A0 (es)
AR (1) AR098616A1 (es)
AU (1) AU2014366427B2 (es)
BR (1) BR112016012505A2 (es)
CA (1) CA2928987A1 (es)
CL (1) CL2016001473A1 (es)
CR (1) CR20160223A (es)
DO (1) DOP2016000128A (es)
EA (1) EA201691036A1 (es)
EC (1) ECSP16024805A (es)
HK (1) HK1224303A1 (es)
IL (1) IL245399A0 (es)
MA (1) MA39108A1 (es)
MX (1) MX2016007984A (es)
NZ (1) NZ719451A (es)
PE (1) PE20160787A1 (es)
PH (1) PH12016501184A1 (es)
SG (1) SG11201604232TA (es)
TN (1) TN2016000180A1 (es)
TW (1) TW201609129A (es)
WO (1) WO2015094878A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI622596B (zh) * 2015-10-26 2018-05-01 美國禮來大藥廠 升糖素受體促效劑
WO2019140024A1 (en) 2018-01-12 2019-07-18 Eli Lilly And Company Combination therapy
WO2020163125A1 (en) 2019-02-05 2020-08-13 Eli Lilly And Company Glucagon analog agonists and methods of using the same

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008086086A2 (en) 2007-01-05 2008-07-17 Indiana University Research And Technology Corporation Glucagon analogs exhibiting enhanced solubility in physiological ph buffers
CN101983066B (zh) 2008-01-30 2016-06-29 印第安那大学科技研究公司 基于酯的胰岛素前药
KR20110039230A (ko) * 2008-06-17 2011-04-15 인디애나 유니버시티 리서치 앤드 테크놀로지 코퍼레이션 생리학적 ｐＨ 완충액에서 강화된 용해도 및 안정성을 나타내는 글루카곤 유사체
PA8830501A1 (es) 2008-06-17 2010-07-27 Univ Indiana Res & Tech Corp Co-agonistas del receptor de glucagon/glp-1
SG172291A1 (en) 2008-12-19 2011-07-28 Univ Indiana Res & Tech Corp Amide based glucagon superfamily peptide prodrugs
DK2454282T3 (en) 2009-07-13 2015-05-04 Zealand Pharma As acetylated glucagonanaloger
MX342409B (es) 2010-01-20 2016-09-28 Zealand Pharma As Tratamiento de enfermedades cardiacas.
RU2012136450A (ru) 2010-01-27 2014-03-10 Индиана Юниверсити Рисерч Энд Текнолоджи Корпорейшн Конъюгаты антагонист глюкагона - агонист gip и композиции для лечения метаболических расстройств и ожирения
US20130053310A1 (en) * 2010-03-26 2013-02-28 Novo Nordisk A/S Novel glucagon analogues
CN102918055B (zh) * 2010-03-26 2017-03-29 诺沃—诺迪斯克有限公司 新的胰高血糖素类似物
EP2568993A4 (en) 2010-05-13 2014-02-19 Univ Indiana Res & Tech Corp GLUCAGON SUPERFAMILY PEPTIDES WITH G-PROTEIN-COUPLED RECEPTOR ACTIVITY
CN103079587B (zh) 2010-05-13 2016-05-11 印第安纳大学研究及科技有限公司 呈现核激素受体活性的胰高血糖素超家族肽
KR20130086343A (ko) 2010-06-24 2013-08-01 질랜드 파마 에이/에스 글루카곤 유사체
WO2011163012A2 (en) 2010-06-24 2011-12-29 Indiana University Research And Technology Corporation Amide based glucagon superfamily peptide prodrugs
WO2011163473A1 (en) 2010-06-25 2011-12-29 Indiana University Research And Technology Corporation Glucagon analogs exhibiting enhanced solubility and stability in physiological ph buffers
CN103402536A (zh) 2010-12-22 2013-11-20 马克迪亚生物科技公司 用gip和glp-1受体活性的基于胰高血糖素的肽来治疗代谢异常和肥胖的方法
KR20140043709A (ko) 2011-01-20 2014-04-10 질랜드 파마 에이/에스 아실화 글루카곤 유사체와 인슐린 유사체의 조합
EP2691108A1 (en) * 2011-03-28 2014-02-05 Novo Nordisk A/S Novel glucagon analogues
KR101968344B1 (ko) * 2012-07-25 2019-04-12 한미약품 주식회사 옥신토모듈린 유도체를 포함하는 고지혈증 치료용 조성물

Also Published As

Publication number Publication date
ECSP16024805A (es) 2017-02-24
DOP2016000128A (es) 2016-06-30
US9688736B2 (en) 2017-06-27
TN2016000180A1 (en) 2017-10-06
WO2015094878A1 (en) 2015-06-25
EA201691036A1 (ru) 2016-12-30
US20160311883A1 (en) 2016-10-27
PH12016501184A1 (en) 2016-07-25
CN105793282A (zh) 2016-07-20
PE20160787A1 (es) 2016-08-17
MA39108A1 (fr) 2017-11-30
CL2016001473A1 (es) 2017-03-10
JP2017503782A (ja) 2017-02-02
AR098616A1 (es) 2016-06-01
AU2014366427B2 (en) 2017-02-16
AP2016009268A0 (en) 2016-06-30
BR112016012505A2 (pt) 2017-09-26
EP3083669A1 (en) 2016-10-26
TW201609129A (zh) 2016-03-16
IL245399A0 (en) 2016-06-30
SG11201604232TA (en) 2016-07-28
KR20160077215A (ko) 2016-07-01
HK1224303A1 (zh) 2017-08-18
AU2014366427A1 (en) 2016-05-19
NZ719451A (en) 2017-10-27
CA2928987A1 (en) 2015-06-25
CR20160223A (es) 2016-07-12

Similar Documents

Publication Publication Date Title
IN2015DN00598A (es)
IN2013DE00266A (es)
IN2014DE01038A (es)
MX2015008829A (es) Momelotinib deuterado.
CL2015002358A1 (es) Compuestos bicíclicos.
AU2014224814A8 (en) Novel halogen-substituted compounds
PH12016501183A1 (en) Novel compound for treatment of severe hypoglycemia
PH12016501182A1 (en) Novel compound for treatment of severe hypoglycemia
PH12016501184A1 (en) Novel compound for treatment of severe hypoglycemia
MX2015012610A (es) Pacritinib deuterizado.
IN2013CH05395A (es)
UA80618U (en) Use of n-steroylethanolamine as radiomodifier
IN2015KN00386A (es)
UA72478U (ru) Применение полентара как средства фригопротекторного действия
AU350093S (en) Compact
UA103980C2 (ru) Способ консервативного лечения апоплексии яичника с минимальным гемоперитонеумом
UA91886U (uk) 1-трет-бутокси-3-(2,2,6,6-тетраметил-4-гідроксипіперидино)-2-пропанол